Skip to main content
. 2019 Dec 26;19:1080. doi: 10.1186/s12879-019-4669-9

Table 4.

Drugs used to treat influenza-like illness (ILI) from pH1N1 influenza, before sARI onset in 50 severe acute respiratory infection (sARI) cases and during equivalent period after ILI onset in 79 controls

Drugs Number exposed Percent exposed Matched odds ratioa (95%CI)
Case (N = 50) Control (N = 79) Case Control
Glucocorticosteroidsb before sARI onset 17 3 34.0 3.8 17.0(2.1–135.0)
Glucocorticosteroidsb before both pneumonia and SARI 15 2 30.0 2.5 15.0(1.9–120.9)
Pyrazolonesc 13 5 26.0 6.3 3.0(0.8–11.7)
Neuraminidase inhibitor 4 6 8.0 7.6 0.6(0.1–3.4)
Amantidine 3 4 6.0 5.1 0.3(0.0–2.8)
Ribavirin 21 32 42.0 41 1.3(0.5–3.2)
Other antivirals 6 11 38.8 61.2 0.5(0.1–2.5)
Antibiotics 43 63 86.0 79.7 0.8(0.2–2.6)
Acetaminophen 14 12 28.0 15.2
Ibuprofen 11 15 22.0 19.0 0.8(0.2–2.8)
Nimesulide 9 15 18.0 19.0 1.4(0.4–4.4)
Traditional Chinese medicine 28 51 56.0 64.6 1.6(0.7–3.4)

aOdds Ratio is matched by age group and underlying disease, bdexamethasone or methyl prednisolone, caminopyrine or dipyrone